STABILITY INDICATING HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND METFORMIN TABLET DOSAGE FORM

DHANSHRI S NANDRE; AEJAZ AHMED; KHAN GJ

doi:10.22159/ajpcr.2022.v15i10.45616

Authors

DHANSHRI S NANDRE Department of Pharmaceutical Chemistry, JIIU’s Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India. https://orcid.org/0000-0002-9706-3985
AEJAZ AHMED Department of Pharmaceutical Chemistry, JIIU’s Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.
KHAN GJ Department of Pharmaceutical Chemistry, JIIU’s Ali-Allana College of Pharmacy, Akkalkuwa, Nandurbar, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i10.45616

Keywords:

Dapagliflozin, Metformin, Reverse phase high performance liquid chromatography, ICH guidelines, Limit of detection, Limit of quantification, Design expert

Abstract

Objectives: The objective of this study was to developed and validated for the routine analysis of dapagliflozin (DAPA) and metformin (MET) in API and tablet dosage forms.

Methods: The estimation of DAPA and MET was accomplished with C18 column (4.6 × 250 mm and 5 μm particle size) with DAD detector. The mobile phase consists of Methanol: Water 75:25% v/v of pH-3 adjusted with 0.05% OPA at flow rate of 1 mL/min. The detection wavelength was 233nm, respectively.

Results: In the developed method, the retention time of DAPA and MET was found to be 5.099 min and 2.165 min. The reverse phase high performance liquid chromatography method produces linear response that were found in the range of 100–500 μg/mL. The limit of detection and limit of quantification for DAPA were found to be 0.06 μg/mL and 0.1855 μg/mL, respectively and for MET 6.09 μg/mL and 18.45 μg/mL, respectively. Calculated information acquired for both the preliminaries roughly coordinates with the information given by design expert programming which shows the genuineness of the chromatographic condition.

Conclusion: The developed method was validated according to the ICH guidelines. The linearity, precision, range, and robustness were within the limits as specified by the ICH guidelines. Hence, the method was found to be simple, accurate, precise, economic, and reproducible.

Downloads

Download data is not yet available.

References

Tripathi KD. Essential of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers; 2018. p. 294, 299-301.

Suma BV, Deveshwaran R. An overview of analytical methods for dapagliflozin. An antibiotic drug. Int J Pharm Sci Res 2018;10:2688-92.

Kasture AV, Wadodkar SG, Mahadik KR, More HM. A Textbook of Pharmaceutical Analysis. Vol. 2. 10th ed. Pune: Nirali Prakashan; 2004. p. 49-50.

Grace AC, Prabha T, Sivakumar T. Development and validation of high performance liquid chromatographic method for determination of dapagliflozin and its impurities in tablet. Asian J Pharm Clin Res 2019;12:447-53.

Beckett AH, Stenlake GH. Practical Pharmaceutical Chemistry. Vol. 2. 4th ed. New Delhi: CBS Publishers and Distributors; 2004.

Urooj A, Sundar PS, Raja A, Dutt KR, Rao KN, Ramana H. Development of validation of RP-HPLC mehtod for simultaneous estimation of dapagliflozin and metformin in bulk and in synthetic mixture. World J Pharm Pharm Sci 2017;6:2139-59.

Sanagpati M, Dhanalakshmi K, Nagarjunreddy G, Sreenivasa S. Development and validation of a RP-HPLC method for the estimation of dapagliflozin in API. Int J Pharm Sci Res 2014;2:53-64.

Dhale RJ. Degradation pathway proposal, structure elucidation and in silico toxicity evaluation studies for dapagliflozin. J Chromatogr 2019;13:54-67.

Gadipally S. Method development of metfromin hydrochloride RP-HPLC. World J Pharm Pharm Sci;3:1149-59.

Chadalawada PK, Divya V, Adilakshmi C, Sreevidya P, Khan I. RP-HPLC analytical method development and validation of metformin hydrochloride tablets assay. Int J Pharm Biol Sci 2019;9:505-19.

Gopal NM, Sridhar C. A validated stability indicating ultra-performance liquid chromatographic method for simultaneous determination of metformin hydrochloride and empagliflozin bulk drug and tablet dosage form. Int J Appl Pharm 2017;9:45-50. doi: 10.22159/ ijap.2017v9i3.17441

British Pharmacopoeia. British Pharmacopoeia Commission. Vol. 2. London: British Pharmacopoeia; 2015. p. 1292.

The Indian Pharmacoporia. Government of India, Ministry of Health and Family Welfare. Vol. 4. Ghaziabad: The Indian Pharmacopoeia; 2018. p. 2544.

International Council for Harmonisation. Guideline Q2. A Validation of Analytical Procedures: Definations and Terminology. 2005 Incorporated in Q2 (R1). Geneva: International Council for Harmonisation. Guideline; 1995.

International Council for Harmonisation. Guideline Q2. B, Validation of Analytical Procedures: Text and Methodology. In: 2005 incorported in Q2 (R1). Geneva: International Council for Harmonisation; 1996.

International Council for Harmonisation. Stability Testing of New Drug Substance and Products, International. Conference on Harmonization, International Federation of Pharmaceutical Manufacturers Associations. Geneva: International Council for Harmonisation; 1993.

International Council for Harmonisation. Impurities in New Drug Products, International. Conference on Harmonization, International Federation of Pharmaceutical Manufacturers Associations. Geneva: International Council for Harmonisation; 1996.

Madhavi S, Rani AP. Development and validation of a method for simultaneous determination of dapagliflozin and saxagliptin in a formulation by RP-HPLC. World J Pharm Res 2017;6:2277-7105.

Nidhi K, Jayvadan P. Development and validation of a stability indicating RP-HPLC method for the simultaneous estimation of metformin and dapagliflozin presence of their degradation products. A review. Int J Pharm Sci Rev Res 2018; ???:???.

Goday S, Shaik AR, Avula P. Development and validation of LC-ESI-MS based bio analytical method for dapagliflozin and saxagliptin in human plasma. Indian J Pharm Educ Res 2018;52:S277-86.

Bhavyasri K, Surekha T, Sumakanth M. A novel method development ADN validation of dapagliflozin and metformin hydrochloride using simultaneous equation method by UV-visible spectroscopy in bulk and combined pharmaceutical formulation indicating forced degradation studies. J Pharm Sci Res 2020;12:1100-5.

Parmar SH, Luhar SV, Narkhede SB. Development and validation of UV-spectroscopic first derivative and high performance thin layer chromatography analytical methods for simultaneous estimation of dapagliflozin propanedial monohydrate and saxagliptin hydrochloride in synthetic mixture. Eur J Biomed Pharm Sci 2018;5:669-84.

Patel PD, Pandya SS. Valiated RP-HPLC method for simultaneous estimation of Dapagliflozin and metformin hydrochloride in tablet dosage form. Int J Pharm Res Scholars 2018;7:9-15.

Khalil GA, Salama I, Gomaa MS, Helal MA. Validated RP-HPLC method for simultaneous determination of canagliflozin, dapagliflozin, empagliflozin and metformin. Int J Pharm Chem Biol Sci 2018;8:1-13.

Nikam N, Maru A, Jadhav A, Malpure P. Analytical method development and validation of metformin hydrochloride by using RP-HPLC with ICH guidelines. Int J Trend Sci Res Dev 2019;3:415-9.